The odor that shows up after sex

A thin gray-white discharge and a fish-like smell, stronger after sex, is the pattern many people describe when they finally call a clinic. The Centers for Disease Control and Prevention lists those two findings, along with vaginal pain, itching, or burning, burning when peeing, and itching around the outside of the vagina, as the symptoms to watch for. A large share of people with bacterial vaginosis have none of those signs. CDC treatment guidance notes that in a nationally representative survey, most women with BV were asymptomatic.

That gap is why odor alone is a poor do-it-yourself test. Yeast infections, trichomoniasis, and some sexually transmitted infections can overlap with BV. Antifungal cream bought for the wrong condition will not fix a bacterial imbalance, and waiting can matter if you are pregnant.

What BV actually is

BV is a shift in the vaginal microbiome, not a single germ you "catch" the way you catch strep throat. CDC patient information describes it as too much of certain bacteria in the vagina, which throws off the usual balance. The 2021 CDC STI Treatment Guidelines go further: hydrogen peroxide– and lactic acid–producing Lactobacillus species are replaced by high concentrations of anaerobic bacteria, including Gardnerella vaginalis, Prevotella species, Mobiluncus species, Atopobium vaginae, and other BV-associated bacteria. A polymicrobial biofilm on vaginal lining cells is a notable feature.

Researchers still do not know the exact cause. The CDC is explicit that BV can occur without sexual activity, but it rarely affects people who have never had sex. You cannot get it from toilet seats, bedding, or swimming pools.

What raises the risk

CDC patient pages name three everyday factors that upset vaginal bacteria: douching, not using condoms, and having new or multiple sex partners. The STI guidelines add associations with female sex partners, HSV-2, and a rise in BV during menses. They also note that BV prevalence has been reported to be higher among people using copper IUDs, while hormonal contraception does not increase risk and might be protective.

Prevention is imperfect because the biology is incomplete. Steps the CDC says may lower risk are not having sex, limiting the number of sex partners, not douching, and using condoms the right way every time you have sex. The Office on Women's Health, citing Allsworth and Peipert's analysis of 2001–2004 NHANES data, reports that women who douche about once a week are five times more likely to develop BV than women who do not douche. Douching also does not treat odor. It can cover a smell briefly and make diagnosis harder if you do it before an exam.

How a clinician makes the diagnosis

Two bedside systems are still the backbone.

Amsel's criteria, as summarized in the CDC STI guidelines, require at least three of these four:

  • Homogeneous, thin discharge (a milk-like consistency) that smoothly coats the vaginal walls
  • Clue cells on microscopy (vaginal lining cells studded with bacteria)
  • Vaginal fluid pH greater than 4.5
  • A fishy odor of the discharge before or after adding 10% potassium hydroxide (the whiff test)

The Nugent score, from a vaginal Gram stain, is the laboratory reference standard in the same guidelines. A score of 0–3 fits a Lactobacillus-dominant sample, 4–6 is intermediate, and 7–10 is BV. Compared with Nugent scoring, Amsel criteria have been reported at about 37%–70% sensitivity and 94%–99% specificity. Culture of Gardnerella by itself is not recommended, because it is not specific. A Pap test is not useful for diagnosing BV.

Several point-of-care and nucleic acid tests exist for symptomatic people. The CDC says those molecular tests should be used in people who have discharge, odor, or itch, because accuracy in people without symptoms is not well defined. Every person diagnosed with BV should also be tested for HIV and other STIs. BV raises the chance of getting HIV, gonorrhea, chlamydia, trichomoniasis, Mycoplasma genitalium, HPV, and HSV-2.

Antibiotics that are actually recommended

Treatment is recommended when symptoms are present. The established benefit in nonpregnant people is relief of symptoms. Treatment may also lower the chance of acquiring several other infections, though that is a potential benefit, not a guarantee.

CDC recommended regimens are:

  • Metronidazole 500 mg by mouth, twice a day for 7 days
  • Metronidazole gel 0.75%, one full applicator (5 g) in the vagina, once a day for 5 days
  • Clindamycin cream 2%, one full applicator (5 g) in the vagina at bedtime for 7 days

Alternative regimens include clindamycin 300 mg by mouth twice a day for 7 days, clindamycin ovules 100 mg in the vagina at bedtime for 3 days, secnidazole 2 g oral granules as a single dose, tinidazole 2 g by mouth once a day for 2 days, or tinidazole 1 g by mouth once a day for 5 days. No data directly compare oral and topical cure rates. Finish the full course even if the smell fades on day two.

Two practical warnings from the same guideline are easy to miss. Clindamycin cream is oil-based and might weaken latex condoms and diaphragms for 5 days; clindamycin ovules can do the same for 72 hours. And a CDC review found no convincing evidence of a disulfiram-like reaction between alcohol and metronidazole, so the older blanket warning to avoid all alcohol during metronidazole is no longer how the guideline frames it. Tinidazole is grouped with that same statement. If a medicine label you were handed still warns about alcohol, ask the prescriber which instruction to follow.

During treatment, avoid sex or use condoms consistently. Do not douche. The CDC says douching might raise the chance of relapse, and there is no evidence it treats BV.

What does not count as treatment

Lactobacillus probiotics are widely sold for "vaginal balance." The 2021 CDC guidelines reviewed intravaginal Lactobacillus and other probiotic studies and concluded that, overall, no studies support these products as an add-on or as a replacement for antibiotics in BV. One investigational vaginal product, Lactobacillus crispatus CTV-05 (Lactin-V), lowered recurrence at 12 weeks after a course of metronidazole gel in a clinical trial, but the CDC notes it is not FDA-cleared and is not commercially available. High-dose vitamin D has not been shown to cut recurrence and is not recommended.

Boric acid sometimes appears in forums as a home fix. The CDC describes a limited-data sequence for people with multiple recurrences: an oral nitroimidazole (metronidazole or tinidazole 500 mg twice a day for 7 days), then intravaginal boric acid 600 mg daily for 21 days, then suppressive metronidazole gel. That is a clinician-directed plan for repeated relapse, not a first treatment, and boric acid is poisonous if swallowed. Do not start it from a social-media recipe.

When BV comes back

Persistent or recurrent BV is common. A follow-up visit is unnecessary if symptoms resolve. Come back if they return. For a first recurrence, repeating a recommended regimen or switching to a different recommended regimen are both acceptable. For multiple recurrences, twice-weekly metronidazole gel 0.75%, or a 750 mg metronidazole vaginal suppository twice weekly for more than 3 months, has reduced recurrences in studies, but the benefit stops when the medicine stops.

Routine treatment of male sex partners is not recommended. Earlier trials did not show that treating the male partner improved the woman's cure or relapse rate. BV can spread between female sex partners. The CDC patient page says male partners of women with BV do not need treatment.

Pregnancy

If you are pregnant and have BV symptoms, treatment matters. The CDC states that the baby is more likely to be born early or to weigh less than 5.5 pounds. The STI guidelines associate symptomatic BV with premature rupture of membranes, preterm birth, intra-amniotic infection, and postpartum endometritis.

Symptomatic pregnant people can use the recommended regimens, plus oral clindamycin or clindamycin ovules as alternatives. Oral therapy has not been shown to beat topical therapy for cure or for preventing bad pregnancy outcomes. Tinidazole should be avoided in pregnancy. Secnidazole, single-dose clindamycin cream products, and some single-dose metronidazole gels lack enough pregnancy data and should be avoided.

Routine screening of pregnant people who feel fine, whether or not they have a history of preterm birth, is not recommended for the purpose of preventing preterm birth. Asymptomatic treatment studies in higher-risk pregnancies have been mixed, including one trial that found harm.

Metronidazole passes into breast milk. Multi-day lower doses are generally considered compatible with breastfeeding. Some clinicians suggest pausing breastfeeding for 12–24 hours after a single 2 g dose. Ask the pediatric clinician or the prescriber if you are nursing.

If you skip treatment

BV sometimes clears without medicine. Leaving symptomatic BV untreated still carries the risks above: other STIs, including HIV, and, in pregnancy, early delivery and low birth weight. Chlamydia and gonorrhea, which are more likely when BV is present, can lead to pelvic inflammatory disease and later difficulty getting pregnant. None of that means every untreated case ends in those outcomes. It does mean a symptomatic person should be examined rather than waiting it out.

Call a clinician for a new fishy odor, a change in discharge, pain, or bleeding you cannot explain. Go in promptly if you are pregnant, if you have fever or pelvic pain, or if symptoms return soon after antibiotics. A comparison of yeast and BV symptoms is in Yeast Infection vs. BV.

Which detail would you actually tell a clinician first: the smell, the discharge, or the fact that an antifungal did nothing?

Sources

This page is education, not a diagnosis or a prescription. Antibiotic choice, pregnancy treatment, and recurrent BV belong with a clinician who can examine you.